Literature DB >> 17827934

Functional heartburn and non-erosive reflux disease.

Vincenzo Savarino1, Edoardo Savarino, Andrea Parodi, Pietro Dulbecco.   

Abstract

Gastroesophageal reflux disease (GERD) is a common disorder in Western countries. For many years our attention has been focused on patients with erosive esophagitis, but in recent times we have realized that endoscopy-negative reflux disease is the most common presentation of this illness, affecting up to 70% of these individuals. Patients with the non-erosive form (NERD) are a heterogeneous group including various subpopulations with different mechanisms for their main symptom of heartburn: reflux of acidic and non-acidic gastric contents, mucosal hypersensitivity, intraesophageal distension by gas, intraduodenal infusion of fat, muscle contractions and psychological abnormalities. As to esophageal acid exposure, patients with NERD can be subdivided into those with abnormal and normal pH testing. The latter group includes patients with a positive correlation between symptoms and reflux events, in whom heartburn can be controlled by proton pump inhibitor (PPI) therapy. According to the recent Rome III criteria, they are still in the realm of GERD. An additional group is called functional heartburn, because this typical symptom is associated neither with an abnormal pH test nor with a positive symptom index. Their response to PPIs is very disappointing. Therefore, there is an increasing consensus on the fact that they do not have GERD and should be treated with drugs other than PPIs. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827934     DOI: 10.1159/000103879

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  19 in total

Review 1.  Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation.

Authors:  Arne Kandulski; Peter Malfertheiner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-22       Impact factor: 46.802

Review 2.  Proton pump inhibitors: an update of their clinical use and pharmacokinetics.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-08-05       Impact factor: 2.953

3.  The importance of subgrouping refractory NERD patients according to esophageal pH-impedance testing.

Authors:  Edoardo Savarino; Maria Giacchino; Vincenzo Savarino
Journal:  Surg Endosc       Date:  2013-07-12       Impact factor: 4.584

4.  Symptom analysis improves GERD diagnosis and may be helpful to define a successful surgical approach.

Authors:  Nicola de Bortoli; Irene Martinucci; Santino Marchi; Edoardo Savarino
Journal:  Surg Endosc       Date:  2013-08-31       Impact factor: 4.584

5.  The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders.

Authors:  Edoardo Savarino; Chiara De Cassan; Giorgia Bodini; Manuele Furnari; Nicola de Bortoli; Vincenzo Savarino
Journal:  J Gastroenterol       Date:  2014-06-28       Impact factor: 7.527

Review 6.  Esophageal motility abnormalities in gastroesophageal reflux disease.

Authors:  Irene Martinucci; Nicola de Bortoli; Maria Giacchino; Giorgia Bodini; Elisa Marabotto; Santino Marchi; Vincenzo Savarino; Edoardo Savarino
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

7.  [Modern diagnostic tools for esophageal pathologies].

Authors:  A Kandulski; P Malfertheiner; J Weigt
Journal:  Internist (Berl)       Date:  2013-03       Impact factor: 0.743

Review 8.  NERD: an umbrella term including heterogeneous subpopulations.

Authors:  Edoardo Savarino; Patrizia Zentilin; Vincenzo Savarino
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

9.  Risk factors for proton pump inhibitor refractoriness in Chinese patients with non-erosive reflux disease.

Authors:  Xiao-Ping Niu; Bao-Ping Yu; Yun-Dong Wang; Zhen Han; Shao-Fen Liu; Chi-Yi He; Guo-Zheng Zhang; Wan-Chun Wu
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

10.  Alginate controls heartburn in patients with erosive and nonerosive reflux disease.

Authors:  Edoardo Savarino; Nicola de Bortoli; Patrizia Zentilin; Irene Martinucci; Luca Bruzzone; Manuele Furnari; Santino Marchi; Vincenzo Savarino
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.